|
US2016108389A1
|
|
High potency pancreatin pharmaceutical compositions
|
|
WO2015193730A1
|
|
Methods for removing viral contaminants from pancreatic extracts
|
|
CN106659773A
|
|
High potency pancreatin pharmaceutical compositions
|
|
CN106163544A
|
|
Be suitable to enteral digestive enzyme compositions
|
|
CN105209062A
|
|
Composition containing digestive enzymes and nutrients suitable for enteral administration
|
|
US2014127307A1
|
|
Micropellet compositions comprising pancreatin containing digestive enzyme mixture
|
|
AU2012293325A1
|
|
Method for dissolution testing of solid compositions containing digestive enzymes
|
|
NZ713487A
|
|
Pharmaceutical composites of poorly water soluble drugs and polymers
|
|
WO2012052853A2
|
|
Oral dosing device for administration of medication
|
|
CN108187033A
|
|
The low-intensity Cotazym of enteric coating
|
|
CA2807567A1
|
|
Predigested nutritional formula
|
|
TW201210517A
|
|
Predigested nutritional formula
|
|
KR20120136346A
|
|
Fexofenadine microcapsules and compositions containing them
|
|
SG10201405791XA
|
|
Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
|
|
TW201113052A
|
|
Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
|
|
NZ601969A
|
|
Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane
|
|
EP1628642A1
|
|
Controlled drug release composition resistant to in vivo mechanic stress
|
